Cingulate Inc. Schedules June 10th Annual Stockholder Meeting

Ticker: CINGW · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1862150

Cingulate Inc. DEF 14A Filing Summary
FieldDetail
CompanyCingulate Inc. (CINGW)
Form TypeDEF 14A
Filed DateApr 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

Cingulate Inc. DEF 14A filed: Annual meeting June 10, 2025. Get ready to vote!

AI Summary

Cingulate Inc. has filed its definitive proxy statement for its annual meeting of stockholders scheduled for June 10, 2025. The filing, dated April 25, 2025, outlines the agenda and information for shareholders regarding the meeting. Cingulate Inc. is a pharmaceutical preparations company based in Kansas City, Kansas.

Why It Matters

This filing is crucial for Cingulate Inc. shareholders as it details the agenda and voting matters for the upcoming annual meeting, impacting corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating immediate financial distress or significant new risks.

Key Numbers

  • 20250425 — Filing Date (Date the definitive proxy statement was filed with the SEC.)

Key Players & Entities

  • Cingulate Inc. (company) — Registrant
  • 0001641172-25-006260 (filing_id) — Accession Number
  • June 10, 2025 (date) — Annual Meeting Date
  • Kansas City, Kansas (location) — Company Headquarters

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide Cingulate Inc. stockholders with information regarding the company's annual meeting of stockholders.

When is the Cingulate Inc. annual meeting of stockholders scheduled to be held?

The annual meeting of stockholders for Cingulate Inc. is scheduled to be held on June 10, 2025.

Where is Cingulate Inc. headquartered?

Cingulate Inc. is headquartered at 1901 W. 47th Place, Kansas City, Kansas 66205.

What is the SEC file number for Cingulate Inc.?

The SEC file number for Cingulate Inc. is 001-40874.

What is the SIC code for Cingulate Inc.?

The Standard Industrial Classification (SIC) code for Cingulate Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Cingulate Inc. (CINGW).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.